Global Flu Vaccine Competitive Landscape Professional Research Report 2025
Description
Global Flu Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
A flu vaccine, also known as a flu shot, is a preventive immunization designed to protect individuals against influenza viruses. The vaccine typically contains inactivated or attenuated forms of influenza viruses or viral components, allowing the immune system to recognize and produce an immune response without causing the disease. Seasonal flu vaccines are formulated annually to target the specific strains of influenza viruses that are anticipated to be prevalent during the upcoming flu season. The vaccine is administered through injection, and in some cases, a nasal spray formulation is also available. Flu vaccination is a key public health measure, as it helps reduce the severity of illness, prevent complications, and minimize the spread of the flu within communities. It is recommended, especially for vulnerable populations such as young children, the elderly, and individuals with underlying health conditions, to enhance immunity and decrease the overall impact of influenza on public health.
According to DIResearch's in-depth investigation and research, the global Flu Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Flu Vaccine include Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological, SIOBP, GSK, Mylan, CSL, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Flu Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Flu Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Flu Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Flu Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Flu Vaccine Include:
Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Mylan
CSL
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
Flu Vaccine Product Segment Include:
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine
Quadrivalent Influenza Vaccine
Flu Vaccine Product Application Include:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Flu Vaccine Industry PESTEL Analysis
Chapter 3: Global Flu Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Flu Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Flu Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Flu Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Flu Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Flu Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Flu Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Flu Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Flu Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Flu Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Flu Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Flu Vaccine Product by Type
- 1.2.1 Split Influenza Vaccine
- 1.2.2 Pandemic Influenza Vaccine
- 1.2.3 Subunit Influenza Vaccine
- 1.2.4 Quadrivalent Influenza Vaccine
- 1.3 Flu Vaccine Product by Application
- 1.3.1 For Children (6 months to 3 years)
- 1.3.2 For Adults and Children over 3 years
- 1.4 Global Flu Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Flu Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Flu Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Flu Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Flu Vaccine Industry Trends and Innovation
- 1.5.1 Flu Vaccine Industry Trends and Innovation
- 1.5.2 Flu Vaccine Market Drivers and Challenges
- 2 Flu Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Flu Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Flu Vaccine Market Analysis by Regions
- 4.1 Flu Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Flu Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Flu Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Flu Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Flu Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Flu Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Flu Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Flu Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Flu Vaccine Market Size by Type and Application
- 5.1 Global Flu Vaccine Market Size by Type
- 5.1.1 Global Flu Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Flu Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Flu Vaccine Market Size by Application
- 5.2.1 Global Flu Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Flu Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Flu Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Flu Vaccine Market Size by Type
- 6.3.1 North America Flu Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Flu Vaccine Revenue by Type (2020-2032)
- 6.4 North America Flu Vaccine Market Size by Application
- 6.4.1 North America Flu Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Flu Vaccine Revenue by Application (2020-2032)
- 6.5 North America Flu Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Flu Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Flu Vaccine Market Size by Type
- 7.3.1 Europe Flu Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Flu Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Flu Vaccine Market Size by Application
- 7.4.1 Europe Flu Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Flu Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Flu Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Flu Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Flu Vaccine Market Size by Type
- 8.3.1 China Flu Vaccine Sales by Type (2020-2032)
- 8.3.2 China Flu Vaccine Revenue by Type (2020-2032)
- 8.4 China Flu Vaccine Market Size by Application
- 8.4.1 China Flu Vaccine Sales by Application (2020-2032)
- 8.4.2 China Flu Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Flu Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Flu Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Flu Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Flu Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Flu Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Flu Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Flu Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Flu Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Flu Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Flu Vaccine Market Size by Type
- 10.3.1 Latin America Flu Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Flu Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Flu Vaccine Market Size by Application
- 10.4.1 Latin America Flu Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Flu Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Flu Vaccine Market Size by Country
- 10.6 Latin America Flu Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Flu Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Flu Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Flu Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Flu Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Flu Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Flu Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Flu Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Flu Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Flu Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Flu Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Flu Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Flu Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Flu Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Flu Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Hualan Bio
- 13.1.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Hualan Bio Flu Vaccine Product Portfolio
- 13.1.3 Hualan Bio Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 CCBIO
- 13.2.1 CCBIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CCBIO Flu Vaccine Product Portfolio
- 13.2.3 CCBIO Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Aleph Biomedical
- 13.3.1 Aleph Biomedical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Aleph Biomedical Flu Vaccine Product Portfolio
- 13.3.3 Aleph Biomedical Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 SANOFI
- 13.4.1 SANOFI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 SANOFI Flu Vaccine Product Portfolio
- 13.4.3 SANOFI Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Adimmune
- 13.5.1 Adimmune Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Adimmune Flu Vaccine Product Portfolio
- 13.5.3 Adimmune Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 ZYAK
- 13.6.1 ZYAK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 ZYAK Flu Vaccine Product Portfolio
- 13.6.3 ZYAK Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 SINOVAC
- 13.7.1 SINOVAC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 SINOVAC Flu Vaccine Product Portfolio
- 13.7.3 SINOVAC Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Changsheng Biological
- 13.8.1 Changsheng Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Changsheng Biological Flu Vaccine Product Portfolio
- 13.8.3 Changsheng Biological Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 SIOBP
- 13.9.1 SIOBP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 SIOBP Flu Vaccine Product Portfolio
- 13.9.3 SIOBP Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 GSK
- 13.10.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 GSK Flu Vaccine Product Portfolio
- 13.10.3 GSK Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Mylan
- 13.11.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Mylan Flu Vaccine Product Portfolio
- 13.11.3 Mylan Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 CSL
- 13.12.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 CSL Flu Vaccine Product Portfolio
- 13.12.3 CSL Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Aimei Hissen
- 13.13.1 Aimei Hissen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Aimei Hissen Flu Vaccine Product Portfolio
- 13.13.3 Aimei Hissen Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Tianyuan Bio-pharma(Novartis)
- 13.14.1 Tianyuan Bio-pharma(Novartis) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Tianyuan Bio-pharma(Novartis) Flu Vaccine Product Portfolio
- 13.14.3 Tianyuan Bio-pharma(Novartis) Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.15 Simcere Vaxtec
- 13.15.1 Simcere Vaxtec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Simcere Vaxtec Flu Vaccine Product Portfolio
- 13.15.3 Simcere Vaxtec Flu Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Flu Vaccine Industry Chain Analysis
- 14.2 Flu Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Flu Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Flu Vaccine Typical Downstream Customers
- 14.4 Flu Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
